Vena cava thrombosis and pregnancy
Keywords:
vena cava thrombosis, inferior vena cava, pregnancy.Abstract
Introduction: Inferior vena cava thrombosis is infrequent during pregnancy, although it has high morbidity and mortality.Objective: To describe the clinical manifestations and diagnosis of a pregnant with inferior vena cava thrombosis.
Clinical case: Is presented an 18-year-old overweight patient with a history of hormonal contraception, with 8 weeks of gestation, who presented increased volume and pain in the lower right limb. She was diagnosed with thrombosis of the inferior vena cava by Doppler ultrasound and treated with heparin. The thrombosis spread to the lower left limb, with high risk for the mother and the fetus. Low molecular weight heparin therapy and elastic compression were continued. Hematological studies were positive for the V3XL factor XIII mutation in a homozygous state. The patient evolved without complications and was discharged with low molecular weight heparin treatment.
Conclusion: Thrombosis of the inferior vena cava should be suspected, although it is considered a challenge for the medical team. The choice of the most appropriate treatment depends on each individual patient.
Downloads
References
2. Nápoles Méndez D. Nuevos dilemas para la tromboprofilaxis en el embarazo y puerperio. MEDISAN. 2014 [acceso: 03/09/2020]; 18(5):614. Disponible en: https://www. Medigraphic.com/cgi-bin/new/contenido.cgiIDPUBLICACION═5107
3. Ferreiro Hernández LB, Jiménez Hernández MM, Nápoles Méndez D, García Gómez O, Couto Núñez D. Trombosis venosa profunda bilateral en una puérpera. MEDISAN 2015 [acceso: 03/09/2020]; 19(5):22. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015000500011
4. Nápoles Méndez D, Couto Núñez D. Experiencia de 11 años en enfermedad tromboembólica venosa en el periodo grávido puerperal. Rev Cub Obstet Ginecol 2011 [acceso: 03/09/2020]; 37(3): 4-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2011000300002
5. Pottier P, Hardouin JB, Lejeune S, Jolliet P, Gillet B, Planchon B. Immobilization and the risk of venous thromboembolism. A meta-analysis on epidemiological studies. Thrombosis research. 2009 [acceso: 03/09/2020]; 124(4): 468-76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/194817816
6. Fernández L. Inferior Vena Caval Thrombosis. Medscape, Drugs and Diseases, General Surgery; 2022. [acceso: 03/09/2020]. Disponible en: http://emedicine.medscape.com/article/1933035-overview
7. Marik PE, Plante L. Venous thromboembolic disease and pregnancy. N Engl J Med 2008 [acceso: 03/09/2020]; 359(19): 2025-33. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18987370
8. Barco S, Nijkeuter M, Middeldorp S. Pregnancy and venous thromboembolism. Semin Thromb Hemost. 2013 [acceso: 03/09/2020]; 39(5): 549-58. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0033-1343893
9. Patel H, Sun H, Hussain AN, Vakde T. Advances in the Diagnosis of Venous Thromboembolism: A Literature Review. Diagnostics. 2020; 10(6): 365. DOI: 10.3390/diagnostics10060365
10. Kreidy R, Salameh P, Waked M. Lower extremity venous thrombosis in patients younger than 50 years of age. Vasc Health Risk Manag. 2012 [acceso: 03/09/2020]; 8: 161-7. Disponible en: https://www.researchgate.net/publication/221979501
11. Pajor A. Thromboembolism and antithrombotic management in pregnancy. Orv Hetil. 2011 [acceso: 03/09/2020]; 152(21): 815-21. Disponible en: https://akjournals.com/view/journals/650/152/21/article-p815.xml
12. Nicolaides A, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, et al. Cardiovascular Disease Educational and Research Trust; European Venous Forum; North American Thrombosis Forum; International Union of Angiology and Union Internationale du Phlebologie. Thrombophilia. Clin Appl Thromb Hemost. 2013; 19(2): 177-87. DOI: 10.1177/107602961247484De
13. Turner TE, Saeed MJ, Novak E, Brown DL. Association of Inferior Vena Cava Filter Placement for Venous Thromboembolic Disease and a Contraindication to Anticoagulation With 30-Day Mortality. JAMA Network Open. 2018 [acceso: 03/09/2020]; 1(3):180452. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324296/
Published
How to Cite
Issue
Section
License
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.